Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
6.05
-0.80 (-11.68%)
At close: Apr 23, 2025, 4:00 PM
6.03
-0.02 (-0.33%)
Pre-market: Apr 24, 2025, 5:17 AM EDT

Forte Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
40145302132467
Upgrade
Market Cap Growth
386.30%386.30%42.17%-33.49%-93.24%-
Upgrade
Enterprise Value
-19129-16-23-14447
Upgrade
Last Close Price
6.0522.7120.5425.0053.50910.25
Upgrade
PB Ratio
0.742.770.850.540.767.92
Upgrade
P/TBV Ratio
0.762.770.850.540.767.92
Upgrade
Quick Ratio
6.436.4310.1312.9323.9226.01
Upgrade
Current Ratio
6.766.7610.4613.0624.1926.52
Upgrade
Return on Equity (ROE)
-80.82%-80.82%-84.92%-34.54%-43.19%-143.64%
Upgrade
Return on Assets (ROA)
-45.51%-45.51%-50.15%-20.36%-25.69%-25.81%
Upgrade
Return on Capital (ROIC)
-52.11%-52.11%-54.78%-21.61%-26.72%-27.47%
Upgrade
Earnings Yield
-89.10%-24.44%-105.42%-66.09%-68.75%-9.95%
Upgrade
FCF Yield
-77.30%-21.20%-96.44%-38.98%-52.82%-3.94%
Upgrade
Buyback Yield / Dilution
-130.90%-130.90%-81.61%-24.45%-89.81%-249.05%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q